Skip to content
Trial Eligibility
Menu

Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm

NCT07224308

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to evaluate the long-term safety and effectiveness of Ultherapy Prime (MFU-V) for improving lines, wrinkles, laxity, and crepiness of the lower face, submentum, and neck. The study will enroll adult male and female subjects aged 25-65 with moderate to severe lower-face and neck skin laxity who are appropriate candidates for non-invasive ultrasound treatment.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Laxity; Skin

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
25 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
The Levine Center for Plastic Surgery
Last updated on ClinicalTrials.gov
November 4, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • The Levine Center for Plastic Surgery · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.